Cargando…
The role of IFN-gamma in systemic lupus erythematosus: a challenge to the Th1/Th2 paradigm in autoimmunity
The classification of T helper cells into type 1 (Th1) and type 2 (Th2) led to the hypothesis that Th1 cells and their cytokines (interleukin [IL]-2, interferon [IFN]-γ) are involved in cell-mediated autoimmune diseases, and that Th2 cells and their cytokines (IL-4, IL-5, IL-10, IL-13) are involved...
Autores principales: | , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2001
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC128889/ https://www.ncbi.nlm.nih.gov/pubmed/11299053 http://dx.doi.org/10.1186/ar290 |
_version_ | 1782120350066147328 |
---|---|
author | Theofilopoulos, Argyrios N Koundouris, Stefanos Kono, Dwight H Lawson, Brian R |
author_facet | Theofilopoulos, Argyrios N Koundouris, Stefanos Kono, Dwight H Lawson, Brian R |
author_sort | Theofilopoulos, Argyrios N |
collection | PubMed |
description | The classification of T helper cells into type 1 (Th1) and type 2 (Th2) led to the hypothesis that Th1 cells and their cytokines (interleukin [IL]-2, interferon [IFN]-γ) are involved in cell-mediated autoimmune diseases, and that Th2 cells and their cytokines (IL-4, IL-5, IL-10, IL-13) are involved in autoantibody(humoral)-mediated autoimmune diseases. However, this paradigm has been refuted by recent studies in several induced and spontaneous mouse models of systemic lupus erythematosus, which showed that IFN-γ is a major effector molecule in this disease. These and additional findings, reviewed here, suggest that these two cross-talking classes of cytokines can exert autoimmune disease-promoting or disease-inhibiting effects without predictability or strict adherence to the Th1-versus-Th2 dualism. |
format | Text |
id | pubmed-128889 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2001 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-1288892002-10-28 The role of IFN-gamma in systemic lupus erythematosus: a challenge to the Th1/Th2 paradigm in autoimmunity Theofilopoulos, Argyrios N Koundouris, Stefanos Kono, Dwight H Lawson, Brian R Arthritis Res Commentary The classification of T helper cells into type 1 (Th1) and type 2 (Th2) led to the hypothesis that Th1 cells and their cytokines (interleukin [IL]-2, interferon [IFN]-γ) are involved in cell-mediated autoimmune diseases, and that Th2 cells and their cytokines (IL-4, IL-5, IL-10, IL-13) are involved in autoantibody(humoral)-mediated autoimmune diseases. However, this paradigm has been refuted by recent studies in several induced and spontaneous mouse models of systemic lupus erythematosus, which showed that IFN-γ is a major effector molecule in this disease. These and additional findings, reviewed here, suggest that these two cross-talking classes of cytokines can exert autoimmune disease-promoting or disease-inhibiting effects without predictability or strict adherence to the Th1-versus-Th2 dualism. BioMed Central 2001 2001-02-14 /pmc/articles/PMC128889/ /pubmed/11299053 http://dx.doi.org/10.1186/ar290 Text en Copyright © 2001 BioMed Central Ltd |
spellingShingle | Commentary Theofilopoulos, Argyrios N Koundouris, Stefanos Kono, Dwight H Lawson, Brian R The role of IFN-gamma in systemic lupus erythematosus: a challenge to the Th1/Th2 paradigm in autoimmunity |
title | The role of IFN-gamma in systemic lupus erythematosus: a challenge to the Th1/Th2 paradigm in autoimmunity |
title_full | The role of IFN-gamma in systemic lupus erythematosus: a challenge to the Th1/Th2 paradigm in autoimmunity |
title_fullStr | The role of IFN-gamma in systemic lupus erythematosus: a challenge to the Th1/Th2 paradigm in autoimmunity |
title_full_unstemmed | The role of IFN-gamma in systemic lupus erythematosus: a challenge to the Th1/Th2 paradigm in autoimmunity |
title_short | The role of IFN-gamma in systemic lupus erythematosus: a challenge to the Th1/Th2 paradigm in autoimmunity |
title_sort | role of ifn-gamma in systemic lupus erythematosus: a challenge to the th1/th2 paradigm in autoimmunity |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC128889/ https://www.ncbi.nlm.nih.gov/pubmed/11299053 http://dx.doi.org/10.1186/ar290 |
work_keys_str_mv | AT theofilopoulosargyriosn theroleofifngammainsystemiclupuserythematosusachallengetotheth1th2paradigminautoimmunity AT koundourisstefanos theroleofifngammainsystemiclupuserythematosusachallengetotheth1th2paradigminautoimmunity AT konodwighth theroleofifngammainsystemiclupuserythematosusachallengetotheth1th2paradigminautoimmunity AT lawsonbrianr theroleofifngammainsystemiclupuserythematosusachallengetotheth1th2paradigminautoimmunity AT theofilopoulosargyriosn roleofifngammainsystemiclupuserythematosusachallengetotheth1th2paradigminautoimmunity AT koundourisstefanos roleofifngammainsystemiclupuserythematosusachallengetotheth1th2paradigminautoimmunity AT konodwighth roleofifngammainsystemiclupuserythematosusachallengetotheth1th2paradigminautoimmunity AT lawsonbrianr roleofifngammainsystemiclupuserythematosusachallengetotheth1th2paradigminautoimmunity |